Skip to main content
. 2020 Jan 27;157:2. doi: 10.1186/s41065-020-0116-6

Table 4.

Enhancer enrichment analysis of loci in PKD2

Set Cell type All enhancers Strongest enhancers
ID Description Obs Exp Fold P Obs Exp Fold P
1 Huvec umbilical vein endothelial cells 5 1.4 3.6 0.012 4 0.7 5.7 0.005
2 H1 H1 cell line 4 10.5 0.4 0.994 4 0.9 4.5 0.013
HepG2 hepatocelluar carcinoma 24 9.3 2.6 2.50E-05 24 3.1 7.8 < 1.0E-06
Huvec umbilical vein endothelial cells 41 11.4 3.6 < 1.0E-06 29 5.7 5.1 < 1.0E-06
HSMM skeletal muscle myoblasts 30 12.9 2.3 1.80E-05 4 5.7 0.7 0.818
NHLF lung fibrolasts 43 11.6 3.7 < 1.0E-06 15 4.4 3.4 4.20E-05
HMEC mammary epithelial cells 36 15 2.4 1.00E-06 10 5.7 1.7 0.065
GM12878 B-lymohocyte, lymphoblastoid 20 11.8 1.7 0.016 13 4.3 3 4.36E-04
NHEK epidermal keratinocytes 30 13 2.3 2.00E-05 17 5.7 3 7.40E-05

Set one was urate-related SNPs identified in a recent genome-wide association study. Set two was all SNPs in the gene region of PKD2